Singapore markets open in 1 hour 19 minutes
Straits Times Index
3,273.48 +10.72 (+0.33%) S&P 500
4,283.74 +9.70 (+0.23%) Dow
33,999.04 +18.72 (+0.06%) Nasdaq
12,965.34 +27.22 (+0.21%) BTC-USD
23,260.36 -94.96 (-0.41%) CMC Crypto 200
558.74 +1.01 (+0.18%)
AstraZeneca PLC (AZNCF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 10:54AM EDT
| Previous close | 134.13 |
| Open | 129.25 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 129.25 - 130.17 |
| 52-week range | 105.26 - 143.90 |
| Volume | |
| Avg. volume | 2,603 |
| Market cap | 201.697B |
| Beta (5Y monthly) | 0.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.84 (2.16%) |
| Ex-dividend date | 11 Aug 2022 |
| 1y target est | N/A |
- Zacks
Merck (MRK) Enters Into Circular RNA Collaboration With Orna
Merck (MRK) is set to make an upfront payment of $150 million to Orna for rights to the latter's circular RNA technology to make vaccines and therapeutics for infectious disease and oncology.
- Financial Times
AstraZeneca sues former executive over move to rival GSK
Pharma group alleges breach of non-compete agreement to delay start date of departing business development official
- Zacks
AstraZeneca's (AZN) Lynparza sNDA Gets FDA Priority Tag
FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) Lynparza as a combination therapy for patients with metastatic castration-resistant prostate cancer.
© 2022 Yahoo. All rights reserved.
